ISPR (27) BTMD (62) MDWD (60) NAGE (63) ⌘ Pro Terminal →

FitLife Brands Inc. (FTLF) — RQD Stock Rating Cockpit

Q: Should I buy, hold, or sell FTLF stock right now?

FitLife Brands Inc. (FTLF) currently earns a Roarable Rating of D (Sell — SELL) with 48/100 RQD Confidence. Stretched risk/reward at 12x P/E (5% return on capital) under elevated 10-year interest-rate pressure.

Q: What is FTLF's 12-month price target and RQD AI Jury consensus?

FTLF's 12-month base price target is $7.55 (range $5.89 to $20.95), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

$7.91 -4.70% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $7.83

FitLife Brands Inc. (FTLF) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (48/100 · D) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D • SELL / AVOID Cap $74.3M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on FTLF Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is FTLF stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-01, FitLife Brands Inc. (NASDAQ: FTLF) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $7.91 (-4.70% 1D, market cap $74.3M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 7/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, FTLF ranks #386 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does FTLF compare to ISPR and BTMD in the Health Care sector?

▼

Within the Health Care sector (Medicinal Chemicals and Botanical Products), FTLF carries a Roarable D (48/100 RQD), trailing P/E of 11.7x, gross margin of 43.1%, and ROIC of 5.4%. By comparison, ISPR (Ispire Technology Inc.) holds a E grade (27/100 RQD, P/E N/A, ROIC -35.0%, cap $79.1M) and BTMD (Biote Corp. (Class A)) posts a C grade (62/100 RQD, P/E N/A, ROIC 85.0%, cap $42.0M). Among the 5-stock peer group, NAGE leads on earnings multiple (11.4x) while BTMD leads on capital efficiency (85.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for FTLF?

▼

Per FTLF's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001374328), FitLife Brands Inc. generated $15.9M in revenue (-75.3% YoY), $6.3M in net income, and $7.4M in free cash flow against $106.3M in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $7.83 (-1.04%)🧬 Cannibal Buyback (-2.36% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 46.4% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (48/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.6% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-4.6% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for FTLF)Realized 20D OHLCV Swing Band: ±10.1%

Deterministic 5-Pillar Attribution (48/100 Composite)

🔍 WHY FTLF SCORES 48/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Insider Conviction & Share Dilution+16/20 pts (33% of score)

SEC Form 4 / 13F Thermometer: 80% Net Buy • Cannibal Buyback (-2.36% YoY Shares)

▲ #2 Bullish Driver: Macro Regime Fit+12/20 pts (25% of score)

FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 29.2 (OVERSOLD (<32))

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C$9.21-8.9% Next Q

Q2 (-2Q)

Grade C-$8.39-0.5% Next Q

Q3 (-1Q)

Grade C-$8.35-5.3% Next Q

Current

Grade D$7.91-5.6% Hist 90D α

Trajectory: C (56) → D (48)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a FTLF Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While FTLF currently carries a cautious 48/100 (D) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Company leadership has skin in the game with net positive insider conviction.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($9.15) and Max Pain ($8.31) forces dealer call-delta covering toward $20.95.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-2.36% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $FTLF• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “FTLF Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 48%NO 52%Trade / Inspect Odds →

RSI-14 MOMENTUMOVERSOLD (<32)

29.230 Oversold · 70 Hot

ALTMAN-Z SHIELDDISTRESS RISK (<1.8)

1.24>3.0 Fortress Safe

PIOTROSKI F-SCORESOLID CORE (5–6)

6 / 99-Pt Accounting

52-WEEK LASER RANGE2% OF RANGE

L: $8$7.91H: $20

1. Money & Cash Health● WEAK

Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: DRQD 9 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: DRQD 20 / 40

3. Hidden Risks & Market Weather● WARNING

SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: DRQD 19 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

2-of-3 JEV AI Jury Bearish Warning on FTLF

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BEARISH (45)

5.4% ROIC with 43.1% gross margin and 9.96% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BEARISH (35)

Altman-Z 1.24 and Piotroski 6/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

NEUTRAL (53)

20/40 institutional & smart-money positioning score with 12/20 macro alignment.

Bull Case: Why Buyers Like FTLF

✓Company leadership has skin in the game with net positive insider conviction.

Bear Case: What Could Go Wrong

!Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring FTLF)

✓Walkthrough of FTLF's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

FTLF // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -14.49%🛡️ HOLDING TREND SUPPORT

2026-10-30O $8.00H $8.15L $7.81C $7.91VOL 12.3K

RES: $9.44SUP: $7.76SMA50: $9.15SMA200: $11.17

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

FTLF Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 FTLF Butterfly Map → + Track FTLF →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

2.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on FTLF today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for FTLF. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for FTLF today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (FTLF)

Health Care Rank #386 of 1016 ⚔️ ISPR vs FTLF Full Matrix →

1. Head-to-Head Health Care Peer Comparison (FTLF vs. ISPR, BTMD, MDWD, NAGE)

Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, FitLife Brands Inc. (FTLF) ranks #386 by composite RQD confidence (48/100, grade D) and #697 by equity capitalization ($74.3M). Within this direct 5-issuer industry benchmark cohort, NAGE leads on earnings valuation at 11.4x trailing P/E, while BTMD leads on capital efficiency and profitability with 85.0% ROIC and — gross margin. NAGE currently holds the highest overall quantitative score in the immediate peer group at 63/100 (C) compared with FTLF at 48/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
FTLF ACTIVE FitLife Brands Inc.	D	48/100	11.7x	43.1%	5.4%	-4.70%	$74.3M	Benchmark Subject
ISPR Ispire Technology Inc.	E	27/100	—	17.8%	-35.0%	-1.44%	$79.1M	/ispr-vs-ftlf →
BTMD Biote Corp. (Class A)	C	62/100	—	—	85.0%	+1.74%	$42.0M	/btmd-vs-ftlf →
MDWD MediWound Ltd.	C-	60/100	—	—	—	+2.21%	$178.9M	/mdwd-vs-ftlf →
NAGE Niagen Bioscience Inc.	C	63/100	11.4x	64.3%	16.8%	-1.57%	$197.8M	/nage-vs-ftlf →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001374328

In its most recent audited fiscal period (FY2025, filed 2025-12-31), FitLife Brands Inc. (FTLF) reported GAAP revenue of $15.9M (-75.3% vs. FY2024 revenue of $64.5M ) , GAAP net income of $6.3M, operating cash flow of $7.4M, and free cash flow of $7.4M (-22.9% YoY). On the balance sheet, FTLF closed FY2025 with $106.3M in total assets against $0 in total debt (Altman Z-Score: 1.24, Piotroski F-Score: 6/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$15.9M	$6.3M	$7.4M	$7.4M	$106.3M	—
FY2024 (FY)	2024-12-31	$64.5M	$9.0M	$9.6M	$9.6M	$58.5M	$8.6M
FY2023 (FY)	2023-12-31	$0	$5.3M	$4.2M	$4.2M	—	—

3. FTLF Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is FTLF stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does FTLF compare to ISPR and BTMD in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for FTLF?

Where is FTLF trading relative to its 50-day, 200-day, and 52-week technical levels?

FTLF last traded at $7.91 (-4.70% on volume of 21,788 shares), positioning the stock -13.55% below its 50-day simple moving average ($9.15) and -29.19% below its 200-day simple moving average ($11.17). Across its 52-week range of $7.66 to $19.95, FTLF sits at the 2.0% percentile with a 14-day RSI of 29.2 (OVERSOLD (<32)) and an implied next-earnings move of ±10.1% ($7.11 to $8.71).

FTLF Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell FTLF stock right now?

FitLife Brands Inc. (FTLF) currently earns a Roarable Rating of D (Sell — SELL) with 48/100 RQD Confidence. Stretched risk/reward at 12x P/E (5% return on capital) under elevated 10-year interest-rate pressure.

What is FTLF's 12-month price target and RQD AI Jury consensus?

FTLF's 12-month base price target is $7.55 (range $5.89 to $20.95), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: FTLF RQD Cockpit FTLF 12M Forecast FTLF Earnings & Move FTLF Dividends & DRIP FTLF Insiders & 13F FTLF Whale Options FTLF Profit Sankey FTLF News & Why